DCOY

Decoy Therapeutics
DCOY

4 hedge funds and large institutions have $10.5K invested in Decoy Therapeutics in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.6K
2
+$1.17K
3
+$353
4
Morgan Stanley
Morgan Stanley
New York
+$9

Top Sellers

1
-$18.2K
2
-$13K
3
-$7.1K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$7.08K
5
Bank of America
Bank of America
North Carolina
-$23
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
$6.67K
UBS Group
2
UBS Group
Switzerland
$3.57K
ASN
3
Advisory Services Network
Georgia
$268
Morgan Stanley
4
Morgan Stanley
New York
$7
WAM
5
Warberg Asset Management
Illinois
–
SG
6
StoneX Group
New York
–
XT
7
XTX Topco
Cayman Islands
–
Geode Capital Management
8
Geode Capital Management
Massachusetts
–
Bank of America
9
Bank of America
North Carolina
–
Osaic Holdings
10
Osaic Holdings
Arizona
–
DB
11
Danske Bank
Denmark
–